ArticleMolecular neurobiology2025
HINT2-Mediated Mitochondrial Modulation Contributes to G-CSF Neuroprotection in Alcohol Use Disorder-Related Ischemic Stroke.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the role of histidine triad nucleotide-binding protein 2 (HINT2) in regulating mitochondrial dysfunction and oxidative stress in the context of ischemic stroke associated with alcohol use disorder (AUD), and examined whether the neuroprotective effects of granulocyte colony-stimulating factor (G-CSF) are partially dependent on HINT2 signaling. AUD was modeled in male Sprague-Dawley rats using the two-bottle choice paradigm. Focal cerebral ischemia was induced via middle cerebral artery occlusion (MCAO) using the intraluminal filament technique. HINT2 expression was downregulated through administration of small interfering RNA. Animals were randomized into five experimental groups: Sham, AUD, MCAO, G-CSF treatment, and HINT2 inhibition. Mitochondrial membrane potential was assessed via JC-1 staining, and reactive oxygen species (ROS) levels were quantified using 2',7'-dichlorodihydrofluorescein diacetate. Protein expression of HINT2 was evaluated by western blotting. Infarct volume was measured using 2,3,5-triphenyltetrazolium chloride staining, and histopathological changes were analyzed using hematoxylin and eosin staining. Neurological function was evaluated using standardized behavioral assessments. G-CSF administration significantly reduced cerebral infarct volume and improved neurological outcomes in both the AUD and MCAO groups (p < 0.05). G-CSF also partially restored mitochondrial membrane potential and attenuated ROS production (p < 0.05). Under conditions of HINT2 suppression, the effects of G-CSF on ROS reduction and mitochondrial membrane potential were attenuated (p < 0.05). HINT2 expression was downregulated following ischemic insult but was partially restored by G-CSF treatment (p < 0.05). Neurological scores indicated improved functional recovery in G-CSF-treated animals, whereas outcomes were significantly impaired in the HINT2-inhibited group. The findings indicate that HINT2 contributes to the neuroprotective effects of G-CSF in AUD-related ischemic stroke by modulating mitochondrial function and reducing oxidative stress. The G-CSF-HINT2-mitochondrial axis may represent a potential therapeutic target for patients with ischemic stroke and comorbid AUD. Further investigation is warranted to elucidate the underlying mechanisms and therapeutic potential.
Indexed as
Identifiers
41212480What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.